NovaBay Pharmaceuticals, Inc. (NBY) Financials
Stock symbol NBY is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker NBY was renamed to
SDEV
effective 2026-04-06.
NBY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 9.0 million | 31.9 million |
| Sept. 30, 2025 | 3.5 million | 1.9 million |
| June 30, 2025 | 6.9 million | 2.7 million |
| March 31, 2025 | 9.9 million | 3.7 million |
NBY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -2.3 million | 23000 |
| Sept. 30, 2025 | -1.8 million | ? |
| June 30, 2025 | -3.0 million | 4000 |
| March 31, 2025 | -1.3 million | 2000 |
NBY Net Income
No data available :(
NBY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 8.0 million | - | 709000 |
| Sept. 30, 2025 | 2.3 million | - | 821000 |
| June 30, 2025 | 5.3 million | - | 931000 |
| March 31, 2025 | 8.5 million | - | 1.0 million |
NBY Shares Outstanding
NBY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | - | 1.8 million | - |
| Sept. 30, 2025 | - | - | 1.2 million | - |
| June 30, 2025 | - | - | 1.9 million | - |
| March 31, 2025 | - | 10000 | 2.7 million | 1.0 million |
NBY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | -521000 | -479000 |
| Sept. 30, 2025 | 521000 | 479000 |
| June 30, 2025 | - | 38000 |
| March 31, 2025 | 2.3 million | 807000 |
NBY Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NBY
Price: $1.88
52 week price:
Earnings Per Share: -28.50 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 100900
Market Capitalization: 51.9 million